In four trading sessions, investor wealth jumped Rs 8.22 lakh crore as markets continued their rally with the benchmark indices recording life time peaks on Monday. The BSE benchmark index Sensex settled 380.21 points higher at its all-time closing high of 47,353.75 on Monday. The index also scaled its fresh record intra-day peak of 47,406.72.
In the previous trade on Thursday, the 30-share index had surged 529.36 points or 1.14 per cent to close at 46,973.54. Equity markets were closed on Friday for Christmas. In four consecutive trading days of gains, the benchmark index has jumped 1,799.79 points or 3.95 per cent.
Following the upbeat sentiment, the market capitalisation of BSE-listed companies have gained Rs 8,22,841.6 crore to Rs 1,87,02,164.65 crore in the four trading sessions. "Markets started the week on a buoyant note and posted decent gains led by positive global cues. Optimism over news that the US President has signed the stimulus package triggered healthy buying in the equity markets. Besides, participants also took note of the beginning of the vaccine drive in various parts of the world," Ajit Mishra, VP (Research) at Religare Broking Ltd said.
US President Donald Trump has signed into law a massive $2.3 trillion spending bill that includes a $900 billion coronavirus relief package, averting a government shutdown and extending coronavirus aid to millions suffering from the economic impact of the pandemic. Sumeet Bagadia, Executive Director at Choice Broking said Indian equity market commenced the week on a positive note amid positive global cues. Sentiments were also upbeat after the UK and EU agreed to the historic Brexit trade deal, Bagadia added.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
In Monday's trade, from the Sensex chart, Titan, SBI, L&T, Ultratech Cement, IndusInd Bank and Asian Paints were the biggest gainers, climbing as muh as 3.15 per cent. Among the BSE sectoral indices, realty rose 2.65 per cent, metal (2.25 per cent), consumer durables (2.19 per cent), industrials (1.76 per cent) and banks (1.5 per cent).In the broader market, the smallcap and midcap indices gained up to 1.49 per cent.